Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROCRIT in Anemic Cancer Patients Not Receiving Chemotherapy
NCT00350090Phase 3Terminated
- Sponsor
- Ortho Biotech Inc.
- Start
- Sep 2002
- Modality
- Biologic, rProtein (Recombinant Protein)
01
Overview
A Phase 3 trial of epoetin alfa in anemia, sponsored by Ortho Biotech Inc.. Started Sep 2002; status: terminated.
02
Drugs
epoetin alfa
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00350090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00350090.